SUBSCRIBE
SUBSCRIBE

Gossamer Bio

NEWS
Business
Two Former Receptos Execs Launch New San Diego Biotech Startup With $100M
It is not clear what the new company’s focus is just yet.
January 4, 2018
 · 
2 min read
 · 
Mark Terry
Load More
AWARDS
  • NextGen Class of 2019
JOBS
IN THE PRESS
Business
Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update
March 17, 2023
 · 
7 min read
Drug Development
Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH
December 6, 2022
 · 
9 min read
Business
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update
November 3, 2022
 · 
8 min read
Business
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update
August 9, 2022
 · 
7 min read
Deals
Gossamer Bio Announces $120 Million Private Placement Financing
July 13, 2022
 · 
5 min read
Drug Development
Gossamer Bio Announces Publication of Key Preclinical Data in the European Respiratory Journal Highlighting Seralutinib’s Potential for the Treatment of PAH
June 9, 2022
 · 
4 min read
Business
Gossamer Bio Announces First Quarter 2022 Financial Results and Provides Business Update
May 10, 2022
 · 
7 min read
Drug Development
Gossamer Bio Announces GB004 Topline Results from Phase 2 SHIFT-UC Study in Ulcerative Colitis and Provides Corporate Update
April 25, 2022
 · 
7 min read
Business
Gossamer Bio Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Business Update
March 3, 2022
 · 
9 min read
Business
Gossamer Bio to Announce Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 3, 2022
February 28, 2022
 · 
1 min read
Load More